Article
Brochure
Executive Resource
Insight Hub
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Is your transaction a business combination or asset acquisition? Learn how ASC 805 guidance, the screen test and key differences shape reporting.
Learn what recent SEC & PCAOB updates mean for public companies and auditors, including disclosure priorities, audit quality focus and emerging risks.
Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.
Explore current insights on accounting standards, SEC scrutiny and SALT exposure for finance leaders to consider.
Event, 
WebinarDecember 10, 2026 (1:00 PM CT) | Join us for a deep dive into relevant regulatory, accounting and reporting issues that public companies are facing.
September 24, 2026 (1:00 PM CT) | Join us for a deep dive into relevant regulatory, accounting and reporting issues that public companies are facing.
June 18, 2026 (1:00 PM CT) | Join us for a deep dive into relevant regulatory, accounting and reporting issues that public companies are facing.
March 19, 2026 (1:00 PM CT) | Join us for a focused session on risk disclosures, emerging technologies and upcoming reporting deadlines.
During this on-demand webinar we discuss end-of-year tax considerations, timely reminders of accounting pronouncements and updates, and more.
Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
Crypto and stablecoin adoption, board roles in AI and ASC 740 disclosure requirements are topics in Weaver’s Accounting & SEC Update: Q3 2025 summary.
